Cladribine
Product Description
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
Categories
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
More Products from ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (99)
-
Product Bedaquiline Fumarate
Anti-infection APIIn house
CN Status(A) -
Product Belumosudil
Therapeutic Area: Immunology
Status: Early
-
Product Bicalutamide
Oncology APIUSP, EP, ChP+YBH
USDMF, CN Status(A) -
Product Bleomycin Sulfate
Oncology APIUSP, EP, IP
USDMF, CEP -
Product Capivasertib
Therapeutic Area: Oncology
Status: Early
-
Product Cenobamate
Therapeutic Area: Epilepsy
Status: Early
-
Product Cyclophosphamide
Oncology APIUSP, EP, ChP+YBH
USDMF, CN Status(A) -
Product Cycloserine
Anti-infection APIYBH
-
Product Cytarabine HCl
Oncology API ChP+YBHCN Status(A) -
Product Dalbavancin
Therapeutic Area: Infection
Status: Early
-
Product Daprodustat
Therapeutic Area: Anemia of CKD
Status: Early
-
Product Darolutamide
Therapeutic Area: Oncology
Status: Early